TrialESMO open2023

Penpulimab combined with anlotinib in patients with R/M HNSCC after failure of platinum-based chemotherapy: a single-arm, multicenter, phase Ⅱ study.

Y Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.